UCB sues MedImmune for Patent Infringement

Biopharmaceutical company UCB Biopharma (Union Chimique Belge is a multinational biopharmaceutical company headquartered in Brussels, Belgium) has filed a complaint against biotech developer MedImmune (MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007) for alleged patent infringement. The case, which was filed in the US District Court for [...]